冲击波联合超短波治疗髌骨软化症的疗效  

Therapeutic Efficacy of Combined Extracorporeal Shock Wave and Ultrashort Wave Therapies in Chondromalacia Patellae

作　　者：王鹏 吴文斌 刘祥宁 李格当 WANG Peng;WU Wen-bin;LIU Xiang-ning;LI Ge-dang(Department of General Surgery,Hospital of Inner Mongolia Autonomous Regional Corps,Chinese People’s Armed Police Forces,Hohhot 010030,China)

机构地区：[1]武警内蒙古自治区总队医院外一科,呼和浩特010030

出　　处：《实用临床医学(江西)》2025年第1期39-42,共4页Practical Clinical Medicine

摘　　要：目的 评估体外冲击波联合超短波治疗髌骨软化症的临床疗效。方法 回顾性分析60例髌骨软化症患者临床资料,所有患者均为青年男性,年龄18~25岁,术前MRI分级均属Ⅱ—Ⅲ级,均采用放射式冲击波联合超短波治疗,完成6个月随访。比较治疗前与治疗后4周、3和6个月患者的视觉模拟评分量表(VAS)评分、Kujala髌骨关节评分、Lysholm膝关节评分。结果 所有患者治疗过程中均未出现局部血肿、瘀紫、点状出血、局部麻木、针刺感、感觉减退、接触性皮炎等并发症。治疗后4周、3和6个月,患者VAS评分明显低于治疗前,Kujala评分和Lysholm评分明显高于治疗前(均P <0.001)。结论 体外冲击波联合超短波治疗可明显减轻髌骨软化症患者膝关节疼痛,以及改善其关节功能。Objective To evaluate the clinical efficacy of extracorporeal shock wave therapy combined with ultrashort wave therapy in the treatment of chondromalacia patellae.Methods A retrospective analysis was conducted on clinical data from 60 male patients(aged 18–25 years)with chondromalacia patellae classified as MRI gradeⅡ–Ⅲ.All patients underwent radial extracorporeal shock wave therapy combined with ultrashort wave therapy and completed 6-month follow-up.Visual Analog Scale(VAS)scores,Kujala patellofemoral scores,and Lysholm knee scores were compared before treatment and at 4 weeks,3 months,and 6 months post-treatment.Results No complications,including local hematoma,ecchymosis,petechial hemorrhage,numbness,paresthesia,hypoesthesia,or contact dermatitis,were observed during treatment.At 4 weeks,3 months,and 6 months after treatment,patients’VAS scores were significantly lower than before treatment,while Kujala and Lysholm scores were significantly higher than before treatment(both P<0.001).Conclusion The combined regimen of extracorporeal shock wave and ultrashort wave therapies can demonstrate positive efficacy in alleviating knee pain and improving joint functionality in patients with chondromalacia patellae.

关 键 词：髌骨软化症 体外冲击波 超短波 功能康复 

分 类 号：R684[医药卫生—骨科学]